|
Volumn 11, Issue 5, 2001, Pages 410-415
|
CD8+ cell changes in psoriasis associated with roxithromycin-induced clinical improvement
a a a |
Author keywords
Cutaneous lymphocyte associated antigen; Immunomodulation; Psoriasis; Roxithromycin; Superantigen
|
Indexed keywords
BACTERIAL ANTIGEN;
CD8 ANTIGEN;
LYMPHOCYTE ANTIGEN;
ROXITHROMYCIN;
SUPERANTIGEN;
T LYMPHOCYTE RECEPTOR;
ADULT;
ANTIBIOTIC THERAPY;
ANTIGEN EXPRESSION;
ANTIGEN PRESENTING CELL;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG MECHANISM;
FEMALE;
HUMAN;
HUMAN CELL;
IMMUNOMODULATION;
LYMPHOCYTE COUNT;
LYMPHOCYTE HOMING;
MALE;
PSORIASIS;
T LYMPHOCYTE SUBPOPULATION;
ADULT;
ANTI-BACTERIAL AGENTS;
ANTIGENS, NEOPLASM;
CD4-POSITIVE T-LYMPHOCYTES;
CD8-POSITIVE T-LYMPHOCYTES;
FEMALE;
FLOW CYTOMETRY;
HISTOCOMPATIBILITY ANTIGENS CLASS II;
HUMANS;
LEUKOCYTES, MONONUCLEAR;
LYMPHOCYTE COUNT;
MALE;
MEMBRANE GLYCOPROTEINS;
MIDDLE AGED;
PSORIASIS;
RECEPTORS, ANTIGEN, T-CELL;
ROXITHROMYCIN;
SEVERITY OF ILLNESS INDEX;
SKIN;
SUPERANTIGENS;
TREATMENT OUTCOME;
|
EID: 0034875341
PISSN: 11671122
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (23)
|
References (32)
|